TheProfitWatch

SLRX - Salarius Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.75 0.1 (13.66%) 0.0 (0.15%) 0.01 (0.86%) 0.05 (6.39%) 0.01 (1.96%) 0.08 (10.42%) -0.01 (-1.47%) 0.01 (0.85%)

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.45
Diluted EPS:
-0.45
Basic P/E:
-1.9044
Diluted P/E:
-1.9044
RSI(14) 1m:
54.94
VWAP:
0.86
RVol:

Events

Period Kind Movement Occurred At

Related News